ACE2 and infection: Additionally, it is noted that modelling data suggests that the neutralisation level required for protection from severe infection is sixfold lower than the level required to protect from any symptomatic infection (21) and thus the lower RBD-ACE2 inhibition levels demonstrated in the vaccination-alone/infection-alone subgroups may still provide a degree of protection over time.